Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

6.670 +0.250 (+3.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
61 62 Next >
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
From Shah Capital
Via GlobeNewswire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report 
Via MarketBeat
Exposures COVID-19
How Is The Market Feeling About Novavax?
Via Benzinga
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
These stocks aren't bargains. 
Via The Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now. 
Via InvestorPlace
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Is there still too much risk surrounding this business? 
Via The Motley Fool
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Catalysts lie ahead for both of these companies. 
Via The Motley Fool
What's Going On With Novavax Stock Today?
In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax representing a 6.66% stake in the company, expressed disappointment with the recent performance of Novavax stock and... 
Via Benzinga
Shah Capital nominates two highly qualified independent director candidates for Novavax
From Shah Capital
Via GlobeNewswire
Better Buy: Bluebird Bio Vs. Novavax
Who wins this face-to-face between two beaten-down biotechs? 
Via The Motley Fool
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. 
Via InvestorPlace
1 Beaten-Down Stock That's Still Not Worth Buying
For this biotech, a rebound seems far too unlikely. 
Via The Motley Fool
Is Novavax a Buy Now?
The stock has dropped 98% over the past three years. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI. 
Via MarketBeat
Topics Cannabis
Exposures Cannabis
1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague
These stocks could move in very different directions over the long run. 
Via The Motley Fool
Three Stocks With The Potential For A Short Squeeze In March
Short squeeze events are heralded by high short interest, trading volume spike, rapid stock price rise, and short interest ratio. Here are three stocks with the potential for a short squeeze in March. 
Via Talk Markets
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy. 
Via InvestorPlace
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
Could these biotech companies still win in the vaccine market and beyond? 
Via The Motley Fool
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation. 
Via InvestorPlace
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell. 
Via InvestorPlace
Exit Alert: 3 Overhyped Stocks With Weak Fundamentals
These are overhyped stocks to sell as they represent companies with weak fundamentals and prospects of cash burn. 
Via InvestorPlace
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Can the stock's recent rally continue? 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Is Advance Auto Parts (AAP) Stock Trending Today?
Advance Auto Parts stock is up on Wednesday even after posting EPS and revenue misses in its earnings report for the fourth quarter of 2023. 
Via InvestorPlace
Why Is COVID-19 Vaccine Maker Novavax Stock Plunging On Wednesday?
Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates COVID-19-Influenza combo vaccine Phase 3 in H2 2024. FY 2024 revenue... 
Via Benzinga
Exposures COVID-19
NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today
Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024! 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.